ENहिन्दी soon
Home/India/Answers/Ozempic in India
INIndia Medicines

Is Ozempic available in India?

GLP Guidebook teamUpdated 5 Oct 202615 sourcesWritten from published sources
The short answer

Yes. Novo Nordisk launched Ozempic (semaglutide) in India in December 2025 for type 2 diabetes. It is a prescription-only weekly pen in 0.25 mg, 0.5 mg and 1 mg strengths. Since 1 April 2026, the 0.25 mg starting dose has an MRP of ₹5,660 for 4 weekly doses. For weight management, Novo sells semaglutide in India as Wegovy.

Before you go further
  • GLP‑1 medicines such as Ozempic are prescription-only in India, not sold over the counter.11
  • A government statement on 1 Apr 2026 said only endocrinologists, internal-medicine specialists and cardiologists can prescribe them.11 CDSCO expert-committee minutes attach a similar condition to some approvals (endocrinologist or internal-medicine specialist), but we found no rule covering every brand.14,15
  • The risks are in Guide 5: Side effects and risks.
  • Nothing here promises any result, and no brand here is a recommendation.

When did Ozempic launch in India, and what is it for?

Novo Nordisk launched Ozempic (semaglutide) in India in December 2025, as a once-weekly injection for type 2 diabetes.1

Business Standard reported the launch on 12 December 2025, at ₹2,200 a week for the lowest dose.1 In India, Ozempic is sold for diabetes, and Wegovy is the brand prescribed for obesity and weight management.2 On 27 February 2026, Abbott said it would sell Novo's semaglutide for diabetes as a second brand, Extensior.4 If diabetes is why you're reading, the type 2 diabetes path covers HbA1c and other diabetes medicines.

Is Ozempic the same medicine as Wegovy?

Ozempic and Wegovy both contain Novo Nordisk's semaglutide, but India sells them for different uses and doses.2,5

Wegovy launched in India on 24 June 2025 for long-term weight management, with a top weekly dose of 2.4 mg.5 Ozempic stops at 1 mg in India.2 Since 1 April 2026, the 0.25 mg starting dose of both costs the same.3 Guide 6 lists which medicines are approved in India, and for what.

Which Ozempic doses are sold, and what is the MRP?

Ozempic comes as a prefilled pen in 3 strengths, at an MRP of ₹5,660 to ₹9,100 for 4 weekly doses.2,3

Novo cut the price of the starting dose by 36% from 1 April 2026, to ₹1,415 a week including taxes.3 Before the cut, the 3 strengths cost ₹8,800 to ₹11,175 for 4 weekly doses.2 The US label starts everyone on 0.25 mg for 4 weeks, and a doctor raises the dose from there.8 That label also has a 2 mg dose, which India's 3 strengths don't include.2,8

StrengthMRPWhere the figure comes from
0.25 mg₹5,660 for 4 weekly dosesNovo Nordisk (₹1,415 a week) and Business Standard, 31 Mar 20262,3
0.5 mg₹8,100 for 4 weekly dosesPrinted MRP on 2 pharmacy listings, Oct 2026; we found no news figure6
1 mg₹9,100 for 4 weekly dosesNovo Nordisk (₹2,275 a week) via Reuters, 1 Apr 2026, and Business Standard2,7

MRPs checked 5 Oct 2026. Each MRP is for one pen. Pharmacies may sell below the MRP.6

Are there generic versions of Ozempic in India?

Yes. Other companies have sold generic semaglutide under their own brand names since the patent expired on 20 March 2026.2,9

Natco launched on 20 March, and Dr Reddy's, Zydus, Alkem, Sun Pharma and Glenmark also launched that month.9,10 By 31 March, at least 17 generic versions were on sale, as pens, vials and tablets.2 Launch prices ran from ₹1,290 to ₹4,200 for 4 starting doses.9,12 For 4 top doses in pens, makers published ₹4,200 to ₹8,000.12,13 Vials are priced differently: Natco's top-strength vial launched at about ₹1,750 a month.9 Some generics are approved for weight management as well as diabetes.10

Novo announced its own price cuts at the end of March, effective 1 April, 12 days after the patent expired.2,3 Guide 6 explains brand versus generic. A post on what changed when the patent expired goes deeper.

RisksThe risks, in brief
  • Stomach effects are common. Feeling sick (nausea) hit 16% on 0.5 mg and 20% on 1 mg. On a dummy injection it was 6% (US label).8
  • Pancreatitis (a swollen pancreas) and gallbladder problems have been reported.8
  • Dehydration from vomiting or diarrhoea can harm the kidneys.8
  • Hypos (low blood sugar) are more likely with insulin or a sulfonylurea.8
  • Thyroid tumours in rodents. The US label carries a boxed warning: semaglutide caused thyroid C-cell tumours in rodents. Whether it does in humans is unknown.8
  • The US label rules it out for anyone with a personal or family history of medullary thyroid cancer or MEN 2; tell your doctor if this applies. It also says to stop at least 2 months before a planned pregnancy.8
Full detail in Guide 5: Side effects and risks →

Read the full picture

Related questions

What is the MRP of Ozempic in India? Is semaglutide the same as Ozempic? Can you take Ozempic if you don't have diabetes? When did semaglutide's patent expire in India? Is Mounjaro available in India?
Did this answer your question?

Sources

  1. Business Standard (Sarjna Rai, citing Reuters). Novo Nordisk launches Ozempic in India at ₹2,200/week amid patent battles, 12 Dec 2025. business-standard.com
  2. Business Standard (Sanket Koul). As generics wave builds up, Novo Nordisk slashes Ozempic, Wegovy prices, 31 Mar 2026 (updated 1 Apr 2026). business-standard.com
  3. Novo Nordisk India announcement, via BioSpectrum India. Novo Nordisk India sets patient-centred price of Rs 202/day for starting dose of Ozempic and Wegovy, 31 Mar 2026. biospectrumindia.com
  4. Abbott India press release. Abbott partners with Novo Nordisk India to launch Extensior, broadening access to semaglutide (Ozempic) for advanced diabetes management, 27 Feb 2026. abbott.in
  5. BusinessToday (Neetu Chandra Sharma). Novo Nordisk launches anti-obesity drug Wegovy in India at Rs 4,336.25 per dose, 24 Jun 2025. businesstoday.in
  6. PharmEasy and MrMed product listings for Ozempic, printed MRP (0.25 mg ₹5,660, 0.5 mg ₹8,100, 1 mg ₹9,100; one prefilled pen each), checked 5 Oct 2026. Used only where 2 pharmacies agree.
  7. ThePrint (Reuters). Novo Nordisk again cuts Ozempic, Wegovy prices by up to 48% in India as generics flood market, 1 Apr 2026. theprint.in
  8. Novo Nordisk. Ozempic (semaglutide) injection US prescribing information, revised 05/2026. US label, not the Indian one: we found no public Indian label. Boxed warning; sections 2.2, 4, 5.1, 5.2, 5.5, 5.6, 5.9, 6.1 (Table 1), 8.3. novo-pi.com
  9. BusinessToday (Neetu Chandra Sharma). NATCO opens semaglutide market at ₹1,290, sets early price benchmark, 20 Mar 2026. businesstoday.in
  10. Pearce IP. Generic semaglutide launches in India, including by Dr Reddy's, Zydus, Alkem, Sun Pharma, Glenmark, 21 Mar 2026. pearceip.law
  11. PIB Research (Government of India). GLP-1 Drugs: Use, Risks, and Regulation. Backgrounder, 1 Apr 2026. pib.gov.in (PDF)
  12. Dr Reddy's Laboratories. Launch of Obeda (semaglutide injection) in India, press release filed with the US SEC, 21 Mar 2026. sec.gov
  13. Sun Pharma. Sun Pharma launches its semaglutide injection under the brand names Noveltreat and Sematrinity in India, press release, 21 Mar 2026. sunpharma.com
  14. CDSCO. Recommendations of the Subject Expert Committee (Endocrinology & Metabolism), 100th meeting, 20–21 Apr 2023, item 1 (tirzepatide, Eli Lilly). Committee minutes, not the final permission. cdsco.gov.in (PDF) · archived copy
  15. CDSCO. Recommendations of the Subject Expert Committee (Endocrinology & Metabolism), 13–14 Feb 2024, items 3–4 (semaglutide, Novo Nordisk). Committee minutes for two named products. cdsco.gov.in (PDF) · archived copy

Last checked 5 Oct 2026 · Next review due 6 Apr 2027 · Report an error

How this answer was made. Written by the GLP Guidebook team from the sources above. We checked each MRP on 5 Oct 2026. It's general information, not medical advice. Talk to a qualified doctor before starting, stopping or changing any medicine. How we write